查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1918311

全球医用气体市场－2026-2031年预测

Global Medical Gas Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 143 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计医用气体市场将从 2025 年的 163.76 亿美元成长到 2031 年的 226.3 亿美元，复合年增长率为 5.54%。

医用气体市场是现代医疗保健基础设施的关键组成部分，涵盖高纯度气体和混合气体的生产、储存、分销和应用，用于治疗、诊断和维持生命。该市场包括医用氧气、氧化亚氮、医用空气、二氧化碳、氮气、氦气和各种麻醉剂重要气体。这些气体的可靠供应对于医院、手术中心、急诊服务和居家医疗的正常运作至关重要，因此该行业既充满活力又不断发展。

成长催化剂和市场驱动因素

慢性病和老龄化相关疾病在全球范围内的日益流行是推动长期氧气疗法（LTOT）和呼吸支持设备需求增长的主要且持续的因素。慢性阻塞性肺病（COPD）、心血管疾病、气喘和睡眠呼吸中止症等疾病直接增加了对长期氧气治疗和呼吸支持设备的需求。此外，全球人口老化和外科技术的进步导致手术数量不断增加，也推动了麻醉气体以及腹腔镜手术和冷冻手术用气体需求的稳定成长。

同时，医疗设备和治疗方法的显着进步正在扩大医用气体的应用范围和消耗量。体外膜氧合（ECMO）在心臟衰竭衰竭治疗中的日益普及，标誌着氧气和二氧化碳的高强度应用。同样，高流量氧气鼻管（HFNC）氧气疗法、非侵入性通气和先进雾化系统的广泛应用，在提高呼吸治疗效果的同时，也增加了对气体的精确度和用量要求。这些技术不仅推动了对气体的需求，也催生了对能够确保安全可控给药的整合输送系统的需求。

市场区隔与应用重点

根据应用领域，市场可大致分为治疗应用与诊断应用两大类。治疗应用领域占据主导地位，涵盖呼吸治疗、麻醉、创伤治疗（高压氧气疗法）、疼痛管理等。诊断应用领域虽然规模较小，但对于肺部弥散测试（使用氦气或一氧化碳）和诊断成像等应用至关重要。慢性病管理和重症监护等治疗领域的成长尤为强劲。

供应链趋势与关键问题

医用气体供应链监管严格且资本密集，从生产到使用环节都需要严格的品管。主要挑战在于关键原材料（尤其是氦气）的价格和供应波动。氦气是核磁共振成像仪和某些呼吸系统应用所必需的，但其供应地域集中，且易受地缘政治因素和产量波动的影响。这种波动会影响营运成本，因此气体生产商和大型医疗网路必须进行策略采购和库存管理。

确保供应链韧性和不间断供应是重中之重，近期国际事件导致氧气供应紧张，凸显了这一点。为此，各国加大了对现场制氧设施（例如，变压式吸附制氧装置）的投资，提升了散装储存能力，并加强了物流合作，以缓解局部短缺和运输伙伴关係。

区域展望：亚太地区将引领快速成长

亚太地区预计将成为医用气体市场成长最快的地区。这一成长主要得益于医疗基础设施的大规模投资，包括在中国、印度和东南亚地区新建医院和专科医疗中心。医疗成本上升、先进医疗服务的普及、慢性病患病率的增加以及政府为改善急诊和重症监护服务而采取的倡议，共同促成了前所未有的市场需求。儘管北美和欧洲仍然是大规模、市场成熟且监管严格的地区，但亚太地区的成长轨迹正在改变全球需求格局，并吸引跨国燃气公司的巨额投资。

竞争格局与策略挑战

市场由大规模全球工业燃气公司主导，这些公司在工业气体和医用气体领域拥有广泛的生产、物流和技术诀窍。竞争主要集中在以下几个方面：

  • 可靠性和纯度：透过强大的生产和分销网络，确保 USP/医用级品质和 24/7 全天候供应可靠性。
  • 综合服务模式：不仅提供燃气供应，还为医疗机构提供设备（歧管、流量计、警报器）、管道安装、维护和合规管理服务。
  • 技术合作：与医疗设备製造商合作，开发用于 ECMO（体外膜氧合）和家庭氧气疗法等先进疗法的整合解决方案。
  • 地理扩张：透过合资、收购或新投资，在快速成长的亚太市场建立生产和分销基地。

医用气体市场正从通用型公用事业到一个高度复杂、技术驱动的产业转型，成为先进医疗保健服务不可或缺的一部分。人口结构和流行病学趋势为市场成长提供了结构性支撑，而医疗程序的创新不断开拓新的应用领域。产业领导者的成功取决于能否应对原物料价格波动、建立具有韧性和灵活性的供应链，以及向高成长的亚太地区进行策略转型。在此过程中，保持作为此关键医疗保健行业基石的卓越安全和品质标准至关重要。

本报告的主要优势：

  • 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
  • 竞争格局：了解全球主要企业的策略倡议，并了解透过正确的策略进入市场的可能性。
  • 市场驱动因素与未来趋势：探索推动市场的动态因素和关键趋势，以及它们将如何塑造未来的市场发展。
  • 可操作的建议：利用这些见解，在快速变化的环境中製定策略决策，发展新的商业机会和收入来源。
  • 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

企业使用我们的报告的目的是什么？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

  • 2021年至2025年的历史数据和2026年至2031年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区（包括国家）分類的收入和预测评估
  • 公司概况（策略、产品、财务资讯）及主要发展动态。

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

5. 全球医用气体市场（依气体类型划分）

  • 介绍
  • 氧
  • 氮
  • 二氧化碳
  • 其他的

6. 全球医用气体市场依应用领域划分

  • 介绍
  • 治疗
  • 诊断
  • 外科手术
  • 其他的

7. 全球医用气体市场（以最终用户划分）

  • 介绍
  • 医院和诊所
  • 手术中心
  • 其他的

8. 全球医用气体市场（依地区划分）

  • 介绍
  • 北美洲
    • 依气体类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 我们
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依气体类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 依气体类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 德国
      • 法国
      • 英国
      • 西班牙
      • 义大利
      • 其他的
  • 中东和非洲
    • 依气体类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 依气体类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 印尼
      • 泰国
      • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • Matheson Tri-Gas, Inc.
  • Linde plc.
  • Air Liquide
  • Atlas Copco
  • Messer
  • Air Products and Chemicals Inc.
  • Taiyo Nippon Sanso Corporation（Mitsubishi Chemical Group）
  • INOX-Air Products Inc.
  • SOL Spa
  • NOVAIR SAS

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061616314

Medical Gas Market is projected to grow at a 5.54% CAGR, increasing from USD 16.376 billion in 2025 to USD 22.63 billion in 2031.

The medical gas market is a critical and foundational component of modern healthcare infrastructure, encompassing the production, storage, distribution, and application of high-purity gases and gas mixtures for therapeutic, diagnostic, and life-support purposes. This market includes essential gases such as medical oxygen, nitrous oxide, medical air, carbon dioxide, nitrogen, helium, and various anesthetic agents. The reliable supply of these gases is non-negotiable for the functioning of hospitals, surgical centers, emergency services, and home healthcare, making it a resilient yet technologically evolving sector.

Growth Catalysts and Market Drivers

A primary and sustained driver is the rising global prevalence of chronic and age-related diseases. Conditions such as chronic obstructive pulmonary disease (COPD), cardiovascular diseases, asthma, and sleep apnea directly increase the demand for long-term oxygen therapy (LTOT) and respiratory support. Furthermore, the growing volume of surgical procedures, driven by an aging global population and advancements in surgical techniques, fuels consistent demand for anesthetic gases and gases used in laparoscopic and cryosurgical applications.

Concurrently, significant technological advancements in medical devices and treatment modalities are expanding the applications and consumption of medical gases. The increased adoption of Extracorporeal Membrane Oxygenation (ECMO) for cardiac and respiratory failure represents a high-intensity use case for oxygen and carbon dioxide. Similarly, the proliferation of high-flow nasal cannula (HFNC) oxygen therapy, non-invasive ventilation, and advanced nebulizer systems enhances the efficacy of respiratory treatments but also increases the precision and volume of gas required. These technologies drive demand for both the gases and the integrated delivery systems that ensure their safe and controlled administration.

Market Segmentation and Application Focus

The market is broadly segmented by application into therapeutic and diagnostic uses. The therapeutic segment dominates, covering respiratory therapy, anesthesia, wound healing (using hyperbaric oxygen), and pain management. The diagnostic segment, though smaller, is vital for applications such as lung diffusion tests (using helium or carbon monoxide) and imaging. Growth is particularly robust in therapeutic areas linked to chronic disease management and critical care.

Supply Chain Dynamics and Critical Challenges

The medical gas supply chain is highly regulated, capital-intensive, and requires stringent quality control from production to point-of-use. A central challenge is price and supply volatility for key raw materials, most notably helium. Helium is critical for MRI scanners and certain respiratory applications, but its supply is geographically concentrated and subject to geopolitical and production fluctuations. This volatility can impact operational costs and necessitate strategic sourcing and inventory management for gas producers and large healthcare networks.

Ensuring supply chain resilience and uninterrupted delivery is paramount, as underscored by recent global events that strained oxygen supply. This has led to increased investment in on-site generation (e.g., pressure swing adsorption plants for oxygen), enhanced bulk storage capabilities, and stronger logistics partnerships to mitigate regional shortages and transportation bottlenecks.

Geographical Outlook: Asia-Pacific as the High-Growth Engine

The Asia-Pacific region is anticipated to be the fastest-growing market for medical gases. This growth is propelled by massive investments in healthcare infrastructure, including the construction of new hospitals and specialty care centers across China, India, and Southeast Asia. Rising healthcare expenditures, increasing accessibility to advanced medical treatments, a growing burden of chronic diseases, and government initiatives to improve emergency and critical care services are all converging to create unprecedented demand. While North America and Europe remain large, mature markets with stringent regulatory frameworks, APAC's growth trajectory is reshaping global demand patterns and attracting significant investment from multinational gas companies.

Competitive Landscape and Strategic Imperatives

The market is dominated by large, global industrial gas corporations that leverage their extensive production, logistics, and technology expertise across both industrial and medical segments. Competition centers on:

  • Reliability and Purity: Guaranteeing USP/medical-grade quality and 24/7 supply reliability through robust production and distribution networks.
  • Integrated Service Models: Offering not just gas, but also equipment (manifolds, flowmeters, alarms), pipeline installation, maintenance, and compliance management services for healthcare facilities.
  • Technology Partnerships: Collaborating with medical device manufacturers to develop integrated solutions for advanced therapies like ECMO and home oxygen therapy.
  • Geographic Expansion: Establishing production and distribution footprints in high-growth APAC markets through joint ventures, acquisitions, or greenfield investments.

The medical gas market is evolving beyond a commoditized utility into a sophisticated, technology-enabled segment vital for advanced healthcare delivery. Growth is structurally supported by demographic and epidemiological trends, while innovation in medical procedures continues to open new application avenues. Success for industry leaders depends on navigating raw material volatility, building resilient and flexible supply chains, and executing a strategic pivot toward the high-growth Asia-Pacific region, all while maintaining the impeccable safety and quality standards that are the bedrock of this essential healthcare sector.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Medical Gas Market Segmentation

  • By Gas Type
  • Oxygen
  • Nitrogen
  • Carbon Dioxide
  • Others
  • By Application
  • Therapeutic
  • Diagnostic
  • Surgery
  • Others
  • By End-User
  • Hospitals & Clinics
  • Surgical Centers
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. MEDICAL GAS MARKET BY GAS TYPE

  • 5.1. Introduction
  • 5.2. Oxygen
  • 5.3. Nitrogen
  • 5.4. Carbon Dioxide
  • 5.5. Others

6. MEDICAL GAS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Therapeutic
  • 6.3. Diagnostic
  • 6.4. Surgery
  • 6.5. Others

7. MEDICAL GAS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals & Clinics
  • 7.3. Surgical Centers
  • 7.4. Others

8. MEDICAL GAS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Gas Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Gas Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Gas Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Spain
      • 8.4.4.5. Italy
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Gas Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Gas Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. India
      • 8.6.4.3. Japan
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Matheson Tri-Gas, Inc.
  • 10.2. Linde plc.
  • 10.3. Air Liquide
  • 10.4. Atlas Copco
  • 10.5. Messer
  • 10.6. Air Products and Chemicals Inc.
  • 10.7. Taiyo Nippon Sanso Corporation (Mitsubishi Chemical Group)
  • 10.8. INOX-Air Products Inc.
  • 10.9. SOL Spa
  • 10.10. NOVAIR SAS

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations